The Egyptan International Company for Pharma Industries (EIPICO) will start production on its third plant in May, thelocal press reports. The factory, based in the Tenth of Ramadan City, cost EIPICO EGP 1 bn and is expected to contribute to the government’s fight against the covid-19 outbreak by producing genetically modified proteins.

Tags: